SBC Medical Group Holdings Inc
For the period ended Sep 30, 2025. Filed Nov 14, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 14, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 5. Other Information
Rule 10b5-1 Trading Arrangements
On September 22, 2025, Yoshiyuki Aikawa, our Chief Executive Officer and Chairman, terminated his previously disclosed Rule 10b5-1 trading arrangement (the "Aikawa Plan"), which provided for the potential sale of up to 1,030,000 shares of the Company’s common stock from September 22, 2025 to September 22, 2026 or an earlier date on which all shares thereunder were to be sold and was intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The Aikawa Plan was terminated prior to execution of any sales pursuant to such plan.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.